Nano-ink gel could replace repeated skull surgeries for kids with rare genetic disorders

This early-stage study aims to develop a personalized treatment for children with syndromic craniosynostosis, a group of rare genetic disorders where skull bones fuse too early. The approach uses a nano-engineered gel to deliver custom genetic medicine directly to the affected area, potentially reducing the need for repeated surgeries. The study involves 12 children aged 0-5 years and will first test the treatment in lab-grown cells and mouse models.